Conduit Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $696,375 | $2,715,194 | $698,221 | $671,992 |
Gross Profit | 258,088 | -515 | -885 | -828 |
EBITDA | 110,415 | -18,878 | -6,282 | -5,143 |
EBIT | 77,959 | -21,287 | -7,167 | -5,971 |
Net Income | 51,027 | -21,325 | -7,118 | -6,028 |
Net Change In Cash | 696,375 | 2,715,194 | 698,221 | 671,992 |
Free Cash Flow | -63,058 | -5,641 | 65,325 | -2,581 |
Cash | 272,151 | 389,887 | 3,838 | 3,332 |
Basic Shares | 39,395 | 160 | 540 | 137 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,715,194 | $922,222 | $0 | $0 |
Gross Profit | 1,031,172 | -457 | ||
EBITDA | 371,519 | -15,839 | 3,053 | -4,887 |
EBIT | 318,163 | -16,296 | -324 | -3,160 |
Net Income | 237,522 | -17,802 | -535 | -4,887 |
Net Change In Cash | 2,715,194 | 922,222 | 0 | 0 |
Free Cash Flow | -17,958 | -9,733 | -7,725 | -2,266 |
Cash | 389,887 | 554 | 4,228 | 345 |
Basic Shares | 160 | 7 | 5 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$231.44 |
2025-09-30 | -$13.16 |
2025-06-30 | -$5.46 |
2025-03-31 | -$19.86 |